The FDA has granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract, after two Phase 3 RCTs showed significant pain reduction in patients with chronic low back pain. VER-01 outperformed opioids on both pain relief and gastrointestinal tolerability, with no evidence of dependence or withdrawal. Here is what this landmark FDA breakthrough therapy cannabis chronic pain milestone means for patients and the physicians treating them
Study Explores Medical Cannabis for Opioid Reduction in Chronic Pain Patients When Cost …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchSafetyPolicyAnxietyMental HealthDosing Why This Matters As opioid-related harms remain a major public health crisis, evidence...
Cannabis Therapy Associated With Sustained Declines in Opioid Use Among Chronic Pain Patients
✦ New CED Clinical Relevance #82 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCBDTHCSafetyMental HealthPolicy Why This Matters Clinicians managing chronic pain patients on opioids need to understand...
New Trial: 1:1 THC:CBD Oil Reduces Fibromyalgia Pain and Improves Sleep
A new double-blind, placebo-controlled trial found that cannabis oil with equal amounts of THC and CBD meaningfully reduced pain and improved sleep in fibromyalgia patients. The trial, conducted across three Australian research institutions, achieved a 92% completion rate with no serious adverse events. Dr. Benjamin Caplan of CED Clinic reviews what the findings mean for patients considering cannabis oil fibromyalgia pain management.
Medical Marijuana Helps Pain Patients Reduce Use Of Opioids, New Study Shows
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchOpioidsMedical MarijuanaAgingSafetyAlternative Medicine Why This Matters Clinicians managing chronic pain patients face mounting pressure to...
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchTHCCBDHempNeurologySafety Why This Matters I need the article summary to write an explanation of its...
Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
✦ New CED Clinical Relevance #82 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCannabisCBDTHCClinical TrialSafety Why This Matters I don't see a summary provided in your request. Please...
Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots
✦ New CED Clinical Relevance #85 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCBDTHCHempCannabis ExtractsSafety Clinical Summary A recent analysis demonstrates that cannabis extracts produce clinically meaningful reductions...
Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML
✦ New CED Clinical Relevance #95 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. PainResearchCBDTHCCannabis ExtractsClinical TrialSafety Why This Matters I'd be happy to help explain the...
California Bill to Authorize Medical Cannabis Drive-Thrus Advances to Assembly Floor Vote
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters This bill could expand patient access to medical cannabis by removing...